Chubb, Toast And A Health Care Stock On CNBC’s ‘Final Trades’

On CNBC’s “ Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, recommended Chubb Limited (NYSE: CB ) as his final trade.

On the earnings front, Chubb, on July 21, reported second-quarter earnings of $7.26 per share, which beat the analyst consensus estimate of $6.75 per share.

The company reported quarterly sales of $12.768 billion, which missed the analyst consensus estimate of $12.987 billion.

Don’t forget to check out our premarket coverage here Bill Baruch, founder and CIO of Blue Line Capital, an investment advisor, named Amgen Inc. (NASDAQ: AMGN ).

Lending support to his choice, Amgen, on Tuesday, reported better-than-expected second-quarter financial results. raised its FY26 adjusted EPS guidance with its midpoint above estimates and raised its FY26 sales guidance above estimates.

Amgen reported quarterly earnings of $6.29 per share.

It beat the analyst consensus estimate of $5.62 per share.

The biopharmaceutical company reported quarterly sales of $10.054 billion, which beat the analyst consensus estimate of $9.421 billion.

Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, picked Toast, Inc. (NYSE: TOST ).

On Tuesday, Toast posted second quarter earnings of 26 cents per share, which beat the analyst consensus estimate of 20 cents per share.

The company’s quarterly sales reached $1.908 billion, beating the analyst consensus estimate of $1.871 billion.

Price Action Amgen shares fell 0.7% to close at $404.85 on Thursday.

Chubb shares gained 0.4% to close at $354.03 during the session.

Toast shares declined 0.2% to close at $34.72 on Thursday.

Read Also: Stock Market Today: Dow Jones Futures Slip, S&P 500 Gains Ahead of July Jobs Report—Atlassian, Trade Desk, Cloudflare in Focus Photo via Shutterstock